These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20618230)

  • 41. Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?
    Ezzat TM; Dhar DK; Newsome PN; Malagó M; Olde Damink SW
    Liver Int; 2011 Jul; 31(6):773-84. PubMed ID: 21645208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting.
    Selden C; Spearman CW; Kahn D; Miller M; Figaji A; Erro E; Bundy J; Massie I; Chalmers SA; Arendse H; Gautier A; Sharratt P; Fuller B; Hodgson H
    PLoS One; 2013; 8(12):e82312. PubMed ID: 24367515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A biodialysis system for liver support tested in a porcine hepatic failure model.
    Sheil AG; Sun J; Wang L; Rao N; Mears DC; Wang C; Woodman K; Johnston B; Watson J
    Aust N Z J Surg; 2000 Feb; 70(2):127-31. PubMed ID: 10711476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioartificial liver attenuates intestinal mucosa injury and gut barrier dysfunction after major hepatectomy: Study in a porcine model.
    Nastos C; Kalimeris K; Papoutsidakis N; Defterevos G; Pafiti A; Kalogeropoulou E; Zerva L; Nomikos T; Papalois A; Kostopanagiotou G; Smyrniotis V; Arkadopoulos N
    Surgery; 2016 Jun; 159(6):1501-1510. PubMed ID: 26847802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a new bioartificial liver using a porcine autologous biomatrix as hepatocyte support.
    Ambrosino G; Varotto S; Stefano Basso SM; Galavotri D; Cecchetto A; Carraro P; Naso A; De Silvestro G; Plebani M; Giron G; Abatangelo G; Donato D; Cestrone A; Marrelli L; Trombetta M; Lorenzelli V; Picardi A; Colantoni A; Van Thiel D; Ricordi C; D'Amico FD
    ASAIO J; 2002; 48(6):592-7. PubMed ID: 12455768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total hepatectomy model in pigs: revised method for vascular reconstruction using a rigid vascular prosthesis.
    Sosef MN; van Gulik TM
    Eur Surg Res; 2004; 36(1):8-12. PubMed ID: 14730217
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pivotal preclinical trial of the spheroid reservoir bioartificial liver.
    Glorioso JM; Mao SA; Rodysill B; Mounajjed T; Kremers WK; Elgilani F; Hickey RD; Haugaa H; Rose CF; Amiot B; Nyberg SL
    J Hepatol; 2015 Aug; 63(2):388-98. PubMed ID: 25817557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive Characterization of a Porcine Model of The "Small-for-Flow" Syndrome.
    Orue-Echebarria MI; Vaquero J; Lisbona CJ; Lozano P; Steiner MA; Morales Á; López-Baena JÁ; Laso J; Hernández I; Olmedilla L; García Sabrido JL; Peligros I; Sola E; Carballal C; Vara E; Asencio JM
    J Gastrointest Surg; 2019 Nov; 23(11):2174-2183. PubMed ID: 30734180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recovery of rats with fulminant hepatic failure by using a hybrid artificial liver support system with polyurethane foam/rat hepatocyte spheroids.
    Sakiyama R; Nakazawa K; Ijima H; Mizumoto H; Kajiwara T; Ito M; Ishibashi H; Funatsu K
    Int J Artif Organs; 2002 Dec; 25(12):1144-52. PubMed ID: 12518958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioartificial liver support for fulminant hepatic failure.
    Anand AC
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S69-74. PubMed ID: 15025261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of a larger version of the hybrid artificial liver support system using a polyurethane foam/spheroid packed-bed module in a warm ischemic liver failure pig model for preclinical experiments.
    Yamashita Y; Shimada M; Tsujita E; Shirabe K; Ijima H; Nakazawa K; Sakiyama R; Fukuda J; Funatsu K; Sugimachi K
    Cell Transplant; 2003; 12(2):101-7. PubMed ID: 12797371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alleviating liver failure conditions using an integrated hybrid cryogel based cellular bioreactor as a bioartificial liver support.
    Damania A; Hassan M; Shirakigawa N; Mizumoto H; Kumar A; Sarin SK; Ijima H; Kamihira M; Kumar A
    Sci Rep; 2017 Jan; 7():40323. PubMed ID: 28079174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure.
    Arkadopoulos N; Chen SC; Khalili TM; Detry O; Hewitt WR; Lilja H; Kamachi H; Petrovic L; Mullon CJ; Demetriou AA; Rozga J
    Cell Transplant; 1998; 7(4):357-63. PubMed ID: 9710304
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Side effects of hybrid liver support therapy: TNF-alpha liberation in pigs, associated with extracorporeal bioreactors.
    Gerlach J; Jörres A; Trost O; Hole O; Vienken J; Courtney JM; Gahl GM; Neuhaus P
    Int J Artif Organs; 1993 Aug; 16(8):604-8. PubMed ID: 8225652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a bioartificial liver with glutamine synthetase-transduced recombinant human hepatoblastoma cell line, HepG2.
    Miyashita T; Enosawa S; Suzuki S; Tamura A; Tanaka H; Amemiya H; Matsumura T; Omasa T; Suga K; Aoki T; Koyanagi Y
    Transplant Proc; 2000 Nov; 32(7):2355-8. PubMed ID: 11120198
    [No Abstract]   [Full Text] [Related]  

  • 56. Semipermeable hollow fiber membranes in hepatocyte bioreactors: a prerequisite for a successful bioartificial liver?
    Flendrig LM; te Velde AA; Chamuleau RA
    Artif Organs; 1997 Nov; 21(11):1177-81. PubMed ID: 9384322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioreactors for extracorporeal liver support.
    Gerlach JC
    Cell Transplant; 2006; 15 Suppl 1():S91-103. PubMed ID: 16826801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lidocaine/monoethylglycinexylidide test, galactose elimination test, and sorbitol elimination test for metabolic assessment of liver cell bioreactors.
    Gerlach JC; Brayfield C; Puhl G; Borneman R; Müller C; Schmelzer E; Zeilinger K
    Artif Organs; 2010 Jun; 34(6):462-72. PubMed ID: 20456323
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioartificial liver support systems.
    Pless G
    Methods Mol Biol; 2010; 640():511-23. PubMed ID: 20645071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model.
    Ho DW; Fan ST; To J; Woo YH; Zhang Z; Lau C; Wong J
    Gut; 2002 Jun; 50(6):869-76. PubMed ID: 12010892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.